Navigation Links
Using Internal Communications to Help Build a Credible External Message Regarding New Pharmaceutical Products
Date:9/17/2010

CHAPEL HILL, N.C., Sept. 17 /PRNewswire/ -- For Pfizer, a key success factor in bringing Viagra successfully to market involved effectively naming and clarifying the condition that the drug was designed to treat. In this process, the brand team was able to shift the nomenclature for the condition from "impotence" (with its negative connotations and somewhat judgmental overtone) to "erectile dysfunction" (more clinical-sounding) to "ED" (casual and conversationally appropriate).

Leading biopharma companies have employed similar naming and communication strategies in introducing other first-in-class therapies for new or socially sensitive conditions like benign prostatic hypertrophy, social phobia, PMS, panic attack, insomnia, restless legs, overactive bladder, HIV and fibromyalgia.

A new Best Practices, LLC benchmarking report, Best Practices for Internal Communications Regarding Brands & Disease State, examines how companies communicate at the brand and disease state levels in order to educate employees internally and build a consistent, credible external message surrounding new products. Comprising in-depth surveys of 32 top biopharma companies and a series of executive interviews, this study will enable marketing and brand team leaders to implement the type of well-timed and well-targeted communications strategies essential for cementing both the medical and commercial framework for a new product's market entry and supporting its overall success as a brand.

Key topics covered in this research include:

  • Ten best practices for internal disease state communication excellence
  • Effective communication channels & use of new communication technologies
  • Timing of communication activities by product development phase
  • Advantages & disadvantages of employee message segmentation
  • Tracking internal message effectiveness
  • Preventing sensitive-information leaks
  • Using KOLs to influence employees
  • Special challenges for products treating socially sensitive conditions or diseases, first-in-class products, or new disease states or conditions
  • Needs creation marketing tactics

To learn more about this report, including information about the research participants, key findings and sample best practices, please download a complimentary excerpt and study overview at: http://www3.best-in-class.com/rr1022.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.  For more information about the company, go to www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
2. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
3. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
4. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
5. Hopkins Report: Focusing on Family Planning Lessens HIV Impact
6. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
7. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
8. Harris Methodist Fort Worth Hospital Using Bubbles to Help Babies Breathe
9. Positive Results Published Using AtriCure Minimally Invasive Products
10. Universite de Montreal Researchers Simulate Worlds Largest Heart Model Using SGI Technology
11. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
(Date:9/9/2017)... 2017 Dealmed Medical Supplies, New ... equipment, supplies, drugs, vaccines, and specialty medical products and ... agreement to acquire Vantage Medical Supplies, a major distributor ... Holtsville, New York . ... emerging medical practices, will operate under the Dealmed name ...
Breaking Medicine Technology:
(Date:9/24/2017)... ... September 24, 2017 , ... “The Gospel Truth Of The Bible: The Other Sheep”: ... Truth Of The Bible: The Other Sheep” is the creation of published author, Maurice Caines. ... the West Indies. He has been a member of the Seventh-day Adventist Church for ...
(Date:9/22/2017)... ... September 22, 2017 , ... MEDIA OPPORTUNITY: , Save Our ... interview citizens on why they are rallying against Mayo Clinic. Specifically, media can talk ... against Dr. Noseworthy’s (CEO) decision to close the Albert Lea hospital. , The rally ...
(Date:9/22/2017)... York (PRWEB) , ... September 22, 2017 , ... ... and assembles Passive House buildings, and Richard Pedranti Architect (RPA), a ... House from the strategic partner’s Solsken Line of Model Homes . Independently, ...
(Date:9/22/2017)... ... September 22, 2017 , ... Happy Living’s mission - to ... carries it into the entertaining and delicious worlds of theatre and wines. ... Happy Living) convinced him to turn his play into a book. The Greener The ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... rooms is celebrating the one year anniversary of its Houston-Fallbrook facility. , ... Dr. Otinwa, Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has ...
Breaking Medicine News(10 mins):